Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 Feb 26;252(3):250–258. doi: 10.1016/j.taap.2011.02.016

Table 3.

Potencies and efficacies of hERG blockers identified from primary qHTS (thallium influx), confirmation (thallium influx), and patch clamp assays

Compound qHTS (two runs) Confirmation Patch clamp
IC50 Efficacy IC50 Efficacy IC50
1,3-diphenylguanidine 3.4 ± 0.3 56 ± 7 6.9 ± 3 39 ± 12 13
2-aminoanthracene* 6.5 ± 2.1 61 ± 3 17.5 ± 26 67 ± 19 >100
3,3,5-trimethylcyclohexylsalicylate 23 ± 23 52 ± 6 Inactive ND
4-N-hexyl-4′-cyanobiphenyl 8.2 ± 2.6 39 ± 6 Inactive ND
benzethonium chloride 2.8 ± 0.5 91 ± 1 3.6 ± 1.4 77 ± 9 0.98
curcumin* 2.6 ± 0.9 129 ± 4 4.4 ± 1.4 140 ± 4 22
D&C red dye 27* 4.5 ± 0.7 119 ± 5 7.0 ± 2.5 173 ± 41 >100
domiphen bromide 7.0 ± 2.8 78 ± 0.6 4.3 ±1.0 62 ± 11 1.5
econazole nitrate 9.1 ± 2.9 109 ± 8 7.2 ± 2.8 112 ± 11 3.5
malachite green oxalate 7.1 ± 0 97 ± 3 4.8 ± 0.8 108 ± 7 1.9
o,p′-DDT 17 ± 11 56 ± 2 22.2 ± 4.1 58 ± 8 2.6
quinidine 11 ± 5.6 107 ± 25 13.6 ± 5.4 110 ± 13 2.1
reserpine 7.5 ± 3.5 125 ± 23 4.9 ± 1.7 118 ± 7 1.9
tamoxifen, citrate salt 6.4 ± 1.0 106 ± 22 8.3 ± 0.8 110 ± 4 4.2
tetra-n-octylammonium bromide 0.38 ± 0.03 102 ± 4 0.26 ± 0.1 100 ± 3 0.082
tricresyl phosphate 14 ± 9 82 ± 11 9.7 ± 1.6 68 ± 16 8.8
trixylenyl phosphate 39 ± 45 67 ± 12 15.9 ± 11 43 ± 15 >100
verapamil 3.1 ± 1.2 105 ± 1 3.4 ± 0.8 100 ± 8 0.2
zinc pyrithione* 3.5 ± 1.4 155 ± 9 3.4 ± 0.3 178 ± 7 33

Abbreviations: DDT = 1,1,1-trichloro-2-(2-chlorophenyl)-2-(4-chlorophenyl)ethane; ND = not determined

*

Inhibition was found in wild type cells.

Each value of potency (IC50, μM) and efficacy (inhibition of thallium influx as a % of positive control) is the mean ± SD of the results from two runs of primary screening and from three experiments, with each concentration tested in duplicate, in the confirmation assay.